This HTML5 document contains 121 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33390060
rdf:type
wikibase:Item
schema:description
articolo scientifico artykuł naukowy 2010年论文 სამეცნიერო სტატია 2010年论文 vedecký článok tudományos cikk tieteellinen artikkeli artigo científico scienca artikolo artigo científico (publicado na 2010) 2010年の論文 wetenschappelijk artikel naučni članak article scientific научни чланак 2010 թվականի հունիսին հրատարակված գիտական հոդված مقالهٔ علمی 2010年論文 article científic 2010年论文 vitskapeleg artikkel บทความทางวิทยาศาสตร์ مقالة علمية bilimsel makale articol științific 2010年论文 2010 թուականի Յունիսին հրատարակուած գիտական յօդուած ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак επιστημονικό άρθρο научная статья teaduslik artikkel мақолаи илмӣ 2010年论文 2010 nî lūn-bûn artikulong pang-agham vetenskaplig artikel artículu científicu espublizáu en 2010 vědecký článek 2010年論文 наукова стаття, опублікована в червні 2010 vitenskapelig artikkel 2010年论文 мақолаи илмӣ سائنسی مضمون 2010년 논문 artigo científico (publicado na 2010) bài báo khoa học מאמר מדעי научна статия 2010年論文 mokslinis straipsnis article scientifique (publié 2010) wissenschaftlicher Artikel artikull shkencor 2010年論文 videnskabelig artikel (udgivet 2010) artículo científico publicado en 2010 2010年論文 scientific article
p:P577
wds:Q33390060-3D9CAE37-0BC5-4021-93AD-A73E2F434468
wdt:P577
2010-06-09T00:00:00Z
p:P2860
wds:Q33390060-D33E0A1A-C438-418A-BDC6-47133B1C3E6C
wdt:P2860
wd:Q33488881
p:P2093
wds:Q33390060-F46688F5-4EDF-4F98-A281-802BBD99A3B2 wds:Q33390060-E2AB5F37-4CC4-497F-A7B0-B5518F634EB6 wds:Q33390060-44CFBB18-77FC-443B-92C5-B8A3F0A70E8A wds:Q33390060-1880C629-695C-4EDA-B558-FAC2793FC8A4 wds:Q33390060-13197B99-A484-4D14-A895-DF7EDC2C0FA7
wdt:P2093
Maria Pastore Giorgio Attinà Patrizia Bertolini Roberta Migliorati Ilaria Lazzareschi
rdfs:label
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
skos:prefLabel
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
schema:name
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma. Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
p:P50
wds:Q33390060-00D0C403-8503-4E99-AE83-2C578B8358D4 wds:Q33390060-380120D0-784E-4DAF-BB32-FD2B3C39807E wds:Q33390060-3DDDCC17-A166-4F2A-9DF2-8E1B2256A6D3 wds:Q33390060-B44A1EDE-6925-4C98-9A38-665A708E19FF wds:Q33390060-F2929A1F-C9EE-4C34-A2E8-D8951C9E5C75 wds:Q33390060-098F3FF4-351B-405F-9886-44DC3BD1C372
wdt:P50
wd:Q57071955 wd:Q39271679 wd:Q56613298 wd:Q43100041 wd:Q48358186 wd:Q73109157
p:P1476
wds:Q33390060-A356A0D2-516E-4499-89C0-194D51DD2EDD
wdt:P1476
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma
p:P304
wds:Q33390060-5D6CEE81-C4EE-4AF9-A431-6F03F124A380
wdt:P304
2943-2949
p:P31
wds:Q33390060-1FD90E84-F173-41CD-AE55-AEA11A636A1B
wdt:P31
wd:Q13442814
p:P921
wds:Q33390060-33A8BF33-12B3-4771-8A5D-1E450B8E2B35 wds:Q33390060-497CFFCA-D713-485E-BCED-05109C9CD8DA wds:Q33390060-993122E5-7B00-49F3-A7D9-3DD9C769B83C
wdt:P921
wd:Q418817 wd:Q1333608 wd:Q425088
p:P698
wds:Q33390060-F737292C-4FC0-4DC0-84AC-DDD9630E59A9
wdtn:P698
n11:20538454
wdt:P698
20538454
p:P1433
wds:Q33390060-35005ECA-DED7-414C-9517-334392CBCA56
wdt:P1433
wd:Q332260
p:P433
wds:Q33390060-EEFF6E32-E308-4FE6-A511-D4D1D3E269CD
p:P478
wds:Q33390060-1F4C1A44-CB68-4D5A-A4F2-0F8D85FD9D72
wdt:P433
16
wdt:P478
46
p:P356
wds:Q33390060-1F61D54A-82F1-47A5-B854-9D4F6F8551FD
wdtn:P356
n12:J.EJCA.2010.05.016
wdt:P356
10.1016/J.EJCA.2010.05.016